Valuation: DexCom, Inc.

Market Cap 28.39B 24.84B 22.9B 21.22B 40.28B 2,694B 40.93B 275B 107B 1,330B 107B 104B 4,596B P/E 2026 *
30.1x
P/E 2027 * 25.2x
Enterprise Value 27.98B 24.49B 22.57B 20.92B 39.71B 2,656B 40.35B 271B 105B 1,311B 105B 103B 4,530B EV / Sales 2026 *
5.36x
EV / Sales 2027 * 4.67x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 week+9.17%
Current month+9.17%
1 month+2.58%
3 months+17.95%
6 months+7.33%
Current year+12.63%
1 week 58.66
Extreme 58.66
64.44
1 month 58.66
Extreme 58.66
68.1
3 years 46.85
Extreme 46.85
132
5 years 46.85
Extreme 46.85
144.8
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%+3.72%-8.95%-44.44% 27.93B
+0.22%+5.62%-28.32%-9.88% 167B
+0.93%+7.16%-4.38%-2.40% 106B
+1.99%+7.60%+0.65%+59.53% 58.09B
-3.29%-4.49%+49.80%+51.92% 52.7B
+0.49%+3.28%-9.63%-39.16% 42.86B
+0.61%+9.05% - - 36.15B
-0.44%-0.81%+60.77%-4.18% 25.27B
-1.31%+2.64%-6.41%+6.13% 20.84B
+0.99%+2.29%-7.68%-1.13% 20.79B
Average +0.01%+3.93%+5.10%+1.82% 58.84B
Weighted average by Cap. +0.19%+4.87%-3.72%+2.63%

Financials

2026 *2027 *
Net sales 5.22B 4.57B 4.21B 3.91B 7.41B 496B 7.53B 50.53B 19.65B 245B 19.62B 19.19B 846B 5.83B 5.1B 4.7B 4.35B 8.27B 553B 8.4B 56.34B 21.91B 273B 21.87B 21.4B 943B
Net income 963M 842M 776M 720M 1.37B 91.36B 1.39B 9.31B 3.62B 45.09B 3.61B 3.54B 156B 1.16B 1.01B 934M 865M 1.64B 110B 1.67B 11.2B 4.35B 54.23B 4.35B 4.25B 187B
Net Debt -405M -354M -327M -303M -575M -38.44B -584M -3.92B -1.52B -18.97B -1.52B -1.49B -65.57B -1.21B -1.06B -977M -905M -1.72B -115B -1.75B -11.71B -4.56B -56.74B -4.55B -4.45B -196B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Date Price Change
26-07-07 €64.40 +1.64%
26-07-06 €63.36 +1.18%
26-07-03 €62.62 +0.22%
26-07-02 €62.48 +3.14%
26-07-01 €60.58 +2.70%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
73.57USD
Average target price
85.24USD
Spread / Average Target
+15.86%

Quarterly revenue - Rate of surprise